local_hospital

Aarhus University

Address
lock Available on a paid plan

Nutritional and Metabolic Diseases

At Aarhus University, the Nephrology research program focuses on Nutritional and Metabolic Diseases, with clinical trials centered on hyperglycaemia after renal transplantation. The studies are designed to assess whether a new oral treatment can help improve blood sugar control alongside standard care.

  • Evaluating hyperglycaemia after renal transplantation in the context of metabolic disease
  • Testing the safety and effectiveness of an oral therapy for better plasma glucose regulation
  • Comparing a new treatment approach with placebo as an add-on to routine care

This research reflects a focused effort to improve diabetes-related management in transplant patients, combining clinical expertise in kidney care with studies aimed at refining treatment options.

Site Overview

assignment
5
connected trials
corporate_fare
2
sponsors
science
5
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
5
Total trials linked
Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
3
Sponsors (total)
2
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +1 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 111 other sites in Denmark

description
Trial volume
5
Outperforms 62% of sites
public
Therapeutic diversity
3areas
Outperforms 52% of sites
groups
Sponsor diversity
2sponsors
Outperforms 47% of sites

Therapeutic Area Benchmark — Denmark

Select a therapeutic area to compare against other sites in Denmark.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Denmark

Market Share

Country: Denmark

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Aarhus University

lock Showing 1 of 5 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Evaluation of Intra-Articular Injection of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Versus Placebo in Patients with Knee OsteoarthritisAarhus UniversitetPhase INot Yet Recruiting

IMP list

lock Showing 1 of 5 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Expanded2Unknown2024-03-072024-03-07

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.